What does Anus Laboratories Limited do?

Anus Laboratories Limited is a Hyderabad-based pharmaceutical company incorporated in 1989. It operates in the Pharmaceutical Manufacturing & APIs sub-sector, though the company appears to be dormant or inactive based on its near-zero share price.

Is Anus Laboratories Limited still active?

The share price of ₹0.01 and absence of publicly available financials or a website strongly suggests the company may be dormant or have ceased active operations. Investors should verify the company's current status on the MCA21 portal.

Is Anus Laboratories Limited listed on any stock exchange?

The CIN prefix 'L' indicates the company was incorporated as a listed entity or intended for listing, but as of current records it is classified as unlisted. Shares may only be available through grey market intermediaries at approximately ₹0.01 per share.

What is the lot size for Anus Laboratories Limited shares?

The lot size is 1 share, making individual share acquisition technically possible, though the company's near-zero price reflects very low investor interest.

Is Anus Laboratories Limited planning an IPO?

There is no publicly available information about any IPO plans. Given the company's near-zero valuation and apparent inactivity, an IPO in the near term is highly unlikely.

Who is the registrar for Anus Laboratories Limited?

The Registrar & Transfer Agent for Anus Laboratories Limited is KFIN Technologies Pvt. Ltd., one of India's leading RTA service providers.

How do I buy Anus Laboratories unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Anus Laboratories?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Anus Laboratories shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Anus Laboratories Unlisted Share Price | Buy Anus Laboratories Pre-IPO Shares — wisefolio

Investment Thesis

Anus Laboratories Limited is a Hyderabad-based pharmaceutical company incorporated in 1989 that appears to be dormant based on its near-zero share price of ₹0.01. With no publicly available financial disclosures, website, or evidence of active operations, this company carries extremely high risk. Investors should avoid unless they have verified current operational status through MCA filings.

Pros

Revenue of ~Rs.256 Cr — meaningful scale pharma API manufacturer based in Hyderabad.
Market leader with >60% global market share in 3 API products; preferred source for 8 others — strong competitive moat.
Export footprint: Israel, Italy, Japan, France, USA, Singapore — well-diversified international customer base.
ISO 9001:2000 certified; two state-of-the-art manufacturing facilities in Hyderabad.
BSE listed (code 532981) — regulated company identity despite current delisted status.

Cons

Delisted — shares no longer traded on exchanges; no secondary market exit for shareholders.
PAT of only Rs.3.44 Cr on Rs.256 Cr revenue — very thin profit margins (~1.3%); profitability challenge.
Exports only 12.37% of turnover — heavy domestic revenue concentration with India pricing pressure.
API manufacturing subject to USFDA/EMA regulatory oversight; any GMP failure can disrupt operations and exports.

Business Segments

API Manufacturing

Manufacture of bulk active pharmaceutical ingredients (APIs) and drug intermediates for global pharma industry.

Pharma Exports

Export of APIs to Israel, Italy, Japan, France, USA, and Singapore — 12.37% of total turnover.

Revenue Model

Sales of pharmaceutical formulations to domestic and export distribution channels; API supply to formulation manufacturers.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds9

Growth Plans

Potential acquisition or revival by a strategic pharmaceutical investor

India's growing pharmaceutical export market could make dormant pharma assets attractive

Shell company restructuring or merger activity

Industry Tailwinds

Potential acquisition or revival by a strategic pharmaceutical investor

Recent Developments

India pharma exports Rs 25+ billion — strong tailwind for Hyderabad manufacturers

India's pharmaceutical exports crossed $25 billion in FY2024 with Hyderabad remaining the epicentre of bulk drug and formulations exports.

FY2024

Comparable Companies

CompanyTypeTickerMkt Cap

Divi's LaboratoriesPE: ~55xxListedDIVISLAB~1,00,000 Cr

Laurus LabsPE: ~35xxListedLAURUSLABS~22,000 Cr

Solara Active Pharma SciencesListedSOLARA~1,500 Cr

Divi's LaboratoriesListed

DIVISLAB · ~1,00,000 Cr

Frequently Asked Questions

About Anus Laboratories

Anus Laboratories Limited is a Hyderabad, Telangana-based pharmaceutical manufacturing company incorporated in 1989. The company is engaged in the manufacture of pharmaceutical formulations and active pharmaceutical ingredients (APIs), operating from Hyderabad — India's premier pharmaceutical manufacturing hub and the world's leading generics production cluster. Hyderabad houses the largest concentration of bulk drug and pharmaceutical manufacturing in India, with over 1,000 pharmaceutical companies including global giants like Dr. Reddy's Laboratories, Aurobindo Pharma, Natco Pharma, and Divi's Laboratories. The city's pharmaceutical ecosystem offers access to skilled scientific talent from premier institutions, established API supply chains, and strong regulatory infrastructure for drug manufacturing compliance. Anus Laboratories has been operating for 35+ years since 1989, building accumulated regulatory approvals, manufacturing expertise, and client relationships in India's pharmaceutical sector. The company was incorporated in the early growth phase of Hyderabad's pharmaceutical emergence as a global hub, benefiting from the cluster's expansion. India is the world's largest producer of generic medicines by volume, supplying approximately 20% of global generics by volume and providing 60% of global vaccine requirements. Hyderabad-based pharmaceutical manufacturers like Anus Laboratories serve both domestic Indian healthcare needs and global generics export markets.

Key Milestones

Incorporated 1989 in Hyderabad, Telangana (CIN: L24230TG1989PLC009977)

Common questions about unlisted shares

How do I buy Anus Laboratories unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Anus Laboratories Limited

How settlement works

Get price alerts for Anus Laboratories Limited

Discuss Anus Laboratories

Similar companies

Other ways to invest